Cycle tracking wearables are being asked to prove clinical grade accuracy, not just convenience
Dr. Dereck Mush, MD, MBA
What they do
The company provides a menstrual tracking application that uses scientific data to help users predict periods, PMS, and fertile windows. It offers a digital birth control feature as a regulated medical device, providing contraception tracking based on user-entered cycle data.
The record
- Vertical
- Women's Health
- Sub-segment
- Menstrual tracking and education
- Product type
- Software as a medical device
- Stage
- Series B
- Headquarters
- Berlin, Germany
- Region
- Europe
- Founded
- 2012
- Total funding
- $48M raised
Notable investors: Balderton Capital, Union Square Ventures, Female Founders Fund.
Also in Women's Health
Related on The Signal
Dr. Dereck Mush, MD, MBA
Top 25 Cardiologists to Follow on LinkedIn in 2026
Dr. Dereck Mush, MD, MBA
Consumer sleep tracking has never been more precise. Diagnosing sleep disorders still requires a lab
Dr. Dereck Mush, MD, MBA
PCOS care platforms are shifting the conversation from fertility to lifelong metabolic health
Dr. Dereck Mush, MD, MBA